Gent M - Search Results

1

Effects on thrombin generation of single injections of Hirulog in patients with calf vein thrombosis.

Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Stevens P, Weitz J, Maraganore J, Hirsh J. Ginsberg JS, et al. Among authors: gent m. Thromb Haemost. 1994 Oct;72(4):523-5. Thromb Haemost. 1994. PMID: 7878625 Clinical Trial.

2

The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement.

Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. Levine MN, et al. Among authors: gent m. Thromb Haemost. 1989 Nov 24;62(3):940-4. Thromb Haemost. 1989. PMID: 2556813

3

Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery.

Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Sicurella J, Brill-Edwards P, Levine MN, Panju AA, Powers P, Stevens P, et al. Ginsberg JS, et al. Among authors: gent m. Circulation. 1994 Nov;90(5):2385-9. doi: 10.1161/01.cir.90.5.2385. Circulation. 1994. PMID: 7955198 Clinical Trial.

4

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, et al. Levine MN, et al. Among authors: gent m. Thromb Haemost. 1995 Aug;74(2):606-11. Thromb Haemost. 1995. PMID: 8584992 Clinical Trial.

5

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.

Anand S, Ginsberg JS, Kearon C, Gent M, Hirsh J. Anand S, et al. Among authors: gent m. Arch Intern Med. 1996 Aug 12-26;156(15):1677-81. Arch Intern Med. 1996. PMID: 8694666

6

The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.

Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, Julian J. Rajan R, et al. Among authors: gent m. Thromb Haemost. 1998 Jan;79(1):19-22. Thromb Haemost. 1998. PMID: 9459315 Clinical Trial.

7

Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.

Crowther MA, Roberts J, Roberts R, Johnston M, Stevens P, Skingley P, Patrassi GM, Sartori MT, Hirsh J, Prandoni P, Weitz JI, Gent M, Ginsberg JS. Crowther MA, et al. Among authors: gent m. Thromb Haemost. 2001 Mar;85(3):390-4. Thromb Haemost. 2001. PMID: 11307802 Clinical Trial.

8

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators. Kearon C, et al. Among authors: gent m. JAMA. 2006 Aug 23;296(8):935-42. doi: 10.1001/jama.296.8.935. JAMA. 2006. PMID: 16926353 Clinical Trial.

9

Low-dose warfarin in rehabilitating stroke survivors.

Ginsberg JS, Bates SM, Oczkowski W, Booker N, Magier D, MacKinnon B, Weitz J, Kearon C, Cruickshank M, Julian JA, Gent M. Ginsberg JS, et al. Among authors: gent m. Thromb Res. 2002 Sep 15;107(6):287-90. doi: 10.1016/s0049-3848(02)00343-2. Thromb Res. 2002. PMID: 12565715 Clinical Trial.

10

Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.

Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank M, Jay R, Gent M. Turpie AG, et al. Among authors: gent m. Chest. 1990 Apr;97(4 Suppl):172S-175S. Chest. 1990. PMID: 2108855 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters